BIOMAT Database Logo BIOMAT Database Logo

[Prevention of obliterating arterial diseases with acetylsalicylic acid]. 1990

P G Berge, and H W Höpp
Klinik III für Innere Medizin, Universität zu Köln.

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001162 Arteriosclerosis Obliterans Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION. Obliterans, Arteriosclerosis
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic

Related Publications

P G Berge, and H W Höpp
[Primary prevention of cardiovascular diseases with acetylsalicylic acid].
December 2005, Deutsche medizinische Wochenschrift (1946),
P G Berge, and H W Höpp
[Significance of acetylsalicylic acid in the secondary prevention of peripheral arterial occlusive diseases].
May 1988, Deutsche medizinische Wochenschrift (1946),
P G Berge, and H W Höpp
Acetylsalicylic acid on primary prevention of cardiovascular diseases.
May 2019, European journal of preventive cardiology,
P G Berge, and H W Höpp
[Amputations in patients with arterial obliterating diseases].
January 1995, Vestnik khirurgii imeni I. I. Grekova,
P G Berge, and H W Höpp
[Amputations in patients with obliterating arterial diseases].
January 1993, Vestnik khirurgii imeni I. I. Grekova,
P G Berge, and H W Höpp
Acetylsalicylic acid and vitamin E in prevention of arterial thrombosis.
May 1997, The Canadian journal of cardiology,
P G Berge, and H W Höpp
[Prevention of reinfarction with acetylsalicylic acid].
January 1979, Folia haematologica (Leipzig, Germany : 1928),
P G Berge, and H W Höpp
[Obliterating arterial systemic diseases in women].
March 1969, Das Deutsche Gesundheitswesen,
P G Berge, and H W Höpp
[Restorative surgery in obliterating arterial diseases].
January 1962, Khirurgiia,
P G Berge, and H W Höpp
[Working capacity in obliterating arterial diseases].
May 1956, Ceskoslovenske zdravotnictvi,
Copied contents to your clipboard!